New cytogenetic prognostic markers in breast cancer;Identificación de nuevos marcadores citogenéticos con valor pronóstico en cáncer de mama

Anales del Sistema Sanitario de Navarra

Volumn 24, Issue 1, 2001, Pages 25-37

  Zudaire, M I ^a   Odero, M D ^a   Caballero, M C ^a   Valenti, C ^a   Martinez Penuela J M ^a   Calasanz, M J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Comparative Genomic Hybridization; Invasive ductal carcinoma; Prognostic factors

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN BCL 2;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 8P; CHROMOSOME LOSS; CHROMOSOME XP; CHROMOSOME XQ; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROGNOSIS;

EID: 0035021547     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cáncer de mama. Clasificación. Etiopatogenia. Manifestaciones clínicas. Actitudes terapéuticas
2. Incidencia del cáncer en Navarra
3. Diagnóstico Precoz
4. Immunohistochemical expression of p53, nm23-Hl, Ki67 and DNA ploidy: Correlation with lymph node status and other clinical pathologic parameters in breast cancer
5. Predicting the future: A critical appraisal of cancer prognosis studies
6. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
7. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
8. Comparative genomic hybridization as a tool in tumour cytogenetics
9. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples
10. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization
11. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DC1S
12. Computer image analysis of comparative genomic hybridization
13. Minimal sizes of deletions detected by comparative genomic hybridization
14. Demystified....Comparative genomic hybridisation
15. Effect of formalin tissue fixation and processing on immunohistochemistry
16. Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization
17. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors
18. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer
19. Strong association between c-myb and oestrogen-receptor expression in human breast cancer
20. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells
21. MYB Oncogene Amplification in Hereditary BRCA1 Breast Cancer
22. Comparative genomic hybridization analysis of 38 breast cancer cell lines: A basis for interpreting complementary DNA microarray data
23. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer
24. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas
25. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization
26. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
27. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer
28. Molecular cytogenetics of primary breast cancer by CGH
29. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression
30. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
31. Node negative breast cancer prognosis and DNA ploidy
32. Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
33. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining
34. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer
35. Genetic alterations in lobular breast cancer by comparative genomic hybridization
36. El consejo médico: La prevención primaria y secundaria de la enfermeda, principios del screening
37. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
38. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
39. Chromosome alterations in breast carcinomas: Frequent involvement of DNA losses including chromosomes 4q and 21q
40. Genetic changes in breast cancer detected by comparative genomic hybridisation